We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$257M
AUM Growth
-$13.3M
Cap. Flow
-$15.3M
Cap. Flow %
-5.95%
Top 10 Hldgs %
43.17%
Holding
259
New
67
Increased
65
Reduced
68
Closed
57

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.62M
2
MCD icon
McDonald's
MCD
+$2.54M
3
MDLZ icon
Mondelez International
MDLZ
+$2.52M
4
CI icon
Cigna
CI
+$2.32M
5
JPM icon
JPMorgan Chase
JPM
+$2.18M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 13.15%
3 Healthcare 9.82%
4 Consumer Discretionary 6.3%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSCO icon
101
Tractor Supply
TSCO
$18.5B
$505K 0.2%
9,355
-9,325
-50% -$501K
GNK icon
102
Genco Shipping & Trading
GNK
$1.09B
$504K 0.2%
23,632
-4,148
-15% -$89.3K
TPH
103
DELISTED
Tri Pointe Homes
TPH
$502K 0.19%
+13,466
New +$507K
LMAT icon
104
LeMaitre Vascular
LMAT
$1.88B
$499K 0.19%
+6,069
New +$446K
OSW icon
105
OneSpaWorld
OSW
$2.63B
$498K 0.19%
32,373
-5,760
-15% -$82.1K
PCAR icon
106
PACCAR
PCAR
$69.7B
$497K 0.19%
4,831
-1,549
-24% -$171K
PAYO icon
107
Payoneer
PAYO
$2.41B
$497K 0.19%
+89,680
New +$485K
ROKU icon
108
Roku
ROKU
$22.4B
$496K 0.19%
8,275
+278
+3% +$16.3K
CHRW icon
109
C.H. Robinson
CHRW
$17.1B
$496K 0.19%
+5,624
New +$449K
CAMT icon
110
Camtek
CAMT
$7.59B
$493K 0.19%
3,934
-3,227
-45% -$308K
ARQT icon
111
Arcutis Biotherapeutics
ARQT
$3.28B
$486K 0.19%
+52,244
New +$472K
HG icon
112
Hamilton Insurance Group
HG
$3.42B
$486K 0.19%
+29,161
New +$446K
CHCO icon
113
City Holding Co
CHCO
$2.04B
$483K 0.19%
+4,549
New +$468K
ITRI icon
114
Itron
ITRI
$4.47B
$481K 0.19%
4,864
-788
-14% -$79.3K
PNTG icon
115
Pennant Group
PNTG
$1.4B
$481K 0.19%
+20,728
New +$454K
ROOT icon
116
Root
ROOT
$800M
$480K 0.19%
9,306
+486
+6% +$28.1K
EVER icon
117
EverQuote
EVER
$907M
$479K 0.19%
22,983
-4,172
-15% -$88.2K
CART icon
118
Maplebear
CART
$11.3B
$477K 0.19%
+14,856
New +$511K
MUSA icon
119
Murphy USA
MUSA
$10.3B
$477K 0.19%
1,015
+229
+29% +$99.8K
WING icon
120
Wingstop
WING
$3.19B
$476K 0.18%
1,126
-432
-28% -$166K
CRTO icon
121
Criteo S.A. Ordinary Shares
CRTO
$898M
$473K 0.18%
+12,541
New +$459K
STLD icon
122
Steel Dynamics
STLD
$38.8B
$472K 0.18%
3,648
+806
+28% +$108K
CDNS icon
123
Cadence Design Systems
CDNS
$90.1B
$472K 0.18%
1,535
+346
+29% +$102K
ALK icon
124
Alaska Air
ALK
$5.4B
$472K 0.18%
+11,685
New +$496K
TOL icon
125
Toll Brothers
TOL
$14.2B
$471K 0.18%
4,090
-3,074
-43% -$372K

Similar funds

Alpha DNA Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Alpha DNA Investment Management held 259 positions worth $257M, down 4.9% from $271M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Alpha DNA Investment Management withdrew a net $15.3M in Q2 2024, closing 57 positions and reducing 68 holdings. Its most notable exit was Cigna, an estimated $2.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Alpha DNA Investment Management opened a new position in Colgate-Palmolive worth $2.32M.

  • Alpha DNA Investment Management's largest Q2 2024 buy was Colgate-Palmolive: 23,939 shares worth $2.32M.
  • Alpha DNA Investment Management added most to Wells Fargo in Q2 2024, an estimated $2.53M increase.
  • Alpha DNA Investment Management's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.62M.
  • Alpha DNA Investment Management fully exited Cigna in Q2 2024, selling an estimated $2.32M.
  • Alpha DNA Investment Management's ten largest holdings make up 43% of its $257M portfolio in Q2 2024.
  • Alpha DNA Investment Management opened 67 new positions and closed 57 in Q2 2024.
  • Alpha DNA Investment Management's portfolio value fell 4.9% quarter-over-quarter to $257M.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.